Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-leucyl-hydroxylamine is a synthetic small molecule and a derivative of the amino acid leucine, classified as an organic compound in the leucine and derivatives group. Its chemical formula is C6H14N2O2, with a molecular weight of approximately 146.19 g/mol[1][5][8]. It is also known as N-hydroxy-L-leucinamide or leucine hydroxamate. The compound has been studied primarily for its enzyme inhibitory properties, particularly its ability to inhibit specific enzymes and influence various metabolic pathways[2]. However, it remains an experimental molecule with no established clinical use or approved therapeutic indications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on L-leucyl-hydroxylamine.